Goal Protocol
Fat Loss
A metabolic pathway centered on appetite signaling, insulin sensitivity, lean-mass preservation and careful dose escalation.
Sustainable fat loss is not a willpower problem — it is a signaling problem. Appetite, satiety, insulin response and energy expenditure are governed by hormones that most conventional diets ignore. This protocol treats fat loss as a metabolic conversation rather than a caloric punishment.
The peptides listed here — most notably the GLP-1 and GLP-1/GIP class — quiet the food-noise that drives grazing, slow gastric emptying, and blunt the glucose spikes that feed fat storage. Used alongside adequate protein, resistance training and sleep, they help preserve lean mass while adipose tissue drops.
This is a medically supervised path, not a cosmetic shortcut. Titration is deliberately slow, side-effects are managed early, and the goal is a metabolism that stays healthier long after the medication is tapered.
GLP-1 receptor agonists mimic a natural gut hormone that signals fullness to the brain and improves insulin release from the pancreas. Add-on molecules like MOTS-c and MQ-NAD-C support the mitochondrial machinery that burns fat for fuel, while AOD-9604 targets lipolysis without disturbing blood sugar. The combination shifts the body from storage to expenditure.
Baseline labs, body composition and medication review. Start protein target (1.6–2.2 g/kg lean mass) and structured resistance training. Introduce the primary agent at the lowest dose to acclimate the gut.
Escalate the primary agent monthly, tracking nausea, hydration, resting heart rate and lean mass. Add mitochondrial support once appetite is stable. Recheck labs at week 12.
Hold the effective dose until body composition goals are met, then taper gradually while reinforcing habits — sleep, steps, protein and strength — that sustain the result.
Anchor every meal with 30–50 g of complete protein to protect lean mass and blunt cravings.
Aim for 7,000–10,000 steps plus two to four resistance sessions weekly; cardio is supportive, not central.
GLP-1 agonists slow gastric emptying — sip water throughout the day and replace sodium, potassium and magnesium.
Under-slept nights raise ghrelin and cortisol; a consistent 7–9 hour window materially improves outcomes.
Most people lose 0.5–1% of body weight per week during titration, with early wins driven by water and glycogen. Meaningful fat loss becomes visible around week 8–12. Plateaus are expected and usually respond to sleep, protein and training adjustments before dose changes.
- Fasting insulin
- Fasting glucose
- HbA1c
- Lipid panel (LDL, HDL, TG, ApoB)
- hs-CRP
- ALT/AST
- TSH, free T3/T4
- Leptin
- Urinalysis with microalbumin
- Urine ketones (during aggressive deficits)
- Personal or family history of medullary thyroid carcinoma or MEN 2 rules out GLP-1 agonists.
- Active gastroparesis, severe reflux or a history of pancreatitis needs specialist input before starting.
- Do not combine with recreational stimulants or aggressive very-low-calorie diets — muscle loss and gallbladder issues accelerate.
Educational content only. Not medical advice. Speak with a qualified clinician before starting any peptide protocol.